© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
Should Drug Approval Decisions Consider Cost?
A newly approved cystic fibrosis drug has an annual wholesale cost of $259,000.
A newly approved cystic fibrosis drug has an annual wholesale cost of $259,000.
J.PMorgan Chase estimated that global sales of this drug could teach $1.6 billion next year and $4.2 billion by 2020. That's a lot of money for a medication that some members of an FDA advisory committee believed had modest effectiveness.
This drug’s hefty price tag raises a few questions, including:
- How long can our health care system sustain high prices for drug that only benefit a small number of patients?
- Will some type of drug rationing result from the high costs?
- Will there be legislation that requires drug approvals based on cost effectiveness?
What do you think?